Korbel Gregory Alan
Insider CIK 1789032 · APRE VP of Business Dev't, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2022-07-28 | 2022-08-01 | 35,700 | — | $0 | 35,700 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2022-07-28 | 2022-08-01 | 24,300 | — | $0 | 45,762 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | F Tax w/h | 2022-06-03 | 2022-06-07 | 8,390 | $0.81 | $6.8K | 21,462 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2022-03-10 | 2022-03-14 | 72,600 | — | $0 | 72,600 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2022-03-10 | 2022-03-14 | 16,000 | — | $0 | 31,841 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | F Tax w/h | 2022-03-10 | 2022-03-14 | 1,989 | $1.82 | $3.6K | 29,852 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | F Tax w/h | 2022-02-25 | 2022-03-01 | 1,326 | $1.74 | $2.3K | 15,841 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise deriv | 2021-12-01 | 2021-12-03 | 27,500 | — | $0 | 2,335 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-03 | 27,500 | $3.96 | $108.9K | 17,167 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise | 2021-12-01 | 2021-12-03 | 27,500 | $0.92 | $25.3K | 44,667 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise deriv | 2021-11-01 | 2021-11-03 | 2,255 | — | $0 | 29,835 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise deriv | 2021-11-01 | 2021-11-03 | 25,245 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise | 2021-11-01 | 2021-11-03 | 27,500 | $0.92 | $25.3K | 44,667 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 27,500 | $5.00 | $137.5K | 17,167 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise deriv | 2021-10-01 | 2021-10-05 | 27,500 | — | $0 | 25,245 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise | 2021-10-01 | 2021-10-05 | 27,500 | $0.92 | $25.3K | 44,667 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 27,500 | $4.89 | $134.5K | 17,167 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise deriv | 2021-09-20 | 2021-09-22 | 27,500 | — | $0 | 52,745 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise | 2021-09-20 | 2021-09-22 | 27,500 | $0.92 | $25.3K | 44,667 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-22 | 27,500 | $4.97 | $136.7K | 17,167 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-22 | 5,460 | $4.98 | $27.2K | 17,167 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | F Tax w/h | 2021-09-10 | 2021-09-14 | 1,724 | $4.59 | $7.9K | 22,627 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | F Tax w/h | 2021-08-25 | 2021-08-27 | 1,149 | $3.98 | $4.6K | 24,351 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2021-03-10 | 2021-03-11 | 15,000 | — | $0 | 25,500 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2021-02-25 | 2021-03-01 | 41,100 | — | $0 | 41,100 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2021-02-25 | 2021-03-01 | 10,000 | — | $0 | 10,500 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2020-03-24 | 2020-03-26 | 12,800 | — | $0 | 12,800 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2019-10-07 | 2019-10-07 | 64,322 | — | $0 | 64,322 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2019-10-07 | 2019-10-07 | 500 | $15.00 | $7.5K | 500 | SEC↗ |